methamphetamine has been researched along with oxidopamine in 101 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 20 (19.80) | 18.7374 |
| 1990's | 34 (33.66) | 18.2507 |
| 2000's | 23 (22.77) | 29.6817 |
| 2010's | 24 (23.76) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ikegami, A; Ozaki, A; Sukamoto, T; Yamashita, A; Yoshidomi, M | 1 |
| Fukuda, H; Ito, H; Ono, H | 1 |
| Hashiguchi, H; Hashitani, T; Ikeda, T; Ishida, Y; Nishino, H; Yamamoto, R | 1 |
| Furuyama, F; Hashitani, T; Isobe, Y; Kanai, M; Kumazaki, M; Nishino, H; Sato, H; Shiosaka, S; Watari, N | 1 |
| Hashitani, T; Ikeda, T; Ishida, Y; Kumazaki, M; Nishino, H | 1 |
| Marek, GJ; Seiden, LS; Vosmer, G | 3 |
| Freed, CR; Richards, JB; Sabol, KE | 1 |
| Axt, KJ; Commins, DL; Seiden, LS; Vosmer, G | 1 |
| Castañeda, E; Robinson, TE; Whishaw, IQ | 1 |
| Gibb, JW; Hanson, GR; Sonsalla, PK | 1 |
| Dunnett, SB; Finger, S | 1 |
| Dunnett, SB; Rogers, DC | 1 |
| Brown, VJ; Dunnett, SB | 1 |
| Seiden, LS | 1 |
| Fukuda, T; Maruyama, Y; Morimoto, Y; Setoguchi, M; Shoji, H; Tsumagari, T | 1 |
| Gibb, JW; Hanson, GR; Johnson, M; Stone, DM | 1 |
| Karadi, Z; Kawamata, S; Nishino, H; Ono, T; Shibata, R; Shiosaka, S; Tohyama, M; Watanabe, H | 1 |
| Arbuthnott, G; Dunnett, SB; Hernandez, TD; Jones, GH; Summerfield, A | 1 |
| Bush, L; Gibb, JW; Hanson, GR; Letter, AA; Merchant, KM | 1 |
| Fujiwara, M; Kataoka, Y; Ohta, H; Sakurai, Y; Shimazoe, T; Ueki, S | 1 |
| Kimura, M; Nishino, H; Ono, T; Shiosaka, S; Takahashi, J; Tohyama, M | 1 |
| Egashira, T; Takano, R; Yamanaka, Y | 1 |
| Dunnett, SB; Jones, GH; Rogers, DC; Whishaw, IQ | 1 |
| Hiyama, Y; Miura, K; Sugita, S; Tanaka, K; Terasawa, K; Watanabe, H | 1 |
| Hsiao, S; Itoh, S; Katsuura, G | 1 |
| Fujiwara, M; Hori, Y; Kataoka, Y; Ueki, S | 1 |
| Fukumori, R; Itoh, K; Suzuki, Y | 1 |
| Seiden, LS; Vosmer, G | 1 |
| Lucot, JB; Schuster, CR; Seiden, LS; Wagner, GC | 1 |
| King, LA; Kita, T; Lowndes, HE; Philbert, MA; Wagner, GC | 1 |
| Lin, JC; Perng, SL; Tsao, WL; Wang, Y | 1 |
| Kamei, H; Kameyama, T; Nabeshima, T | 1 |
| Ando, K; Hironaka, N; Miyata, H; Yanagita, T | 1 |
| Aceves, J; Flores, G; Rosales, MG; Sierra, A; Valencia, J | 1 |
| Hirobe, M; Nagao, T; Ohta, S; Ono, H; Tateyama, M; Watanabe, H | 1 |
| Elayan, I; Foltz, RL; Gibb, JW; Hanson, GR; Johnson, M; Lim, HK | 1 |
| Ohno, M; Watanabe, S; Yoshida, H | 1 |
| Fisher, H; Myers, CS; Wagner, GC | 1 |
| Adams, FS; Edwards-Prasad, J; Freed, CR; Kentroti, S; Kumar, S; La Rosa, FG; Prasad, KN; Vernadakis, A | 1 |
| Hashiguchi, H; Ishida, Y; Kuwahara, I; Mitsuyama, Y; Nishimori, T; Todaka, K | 1 |
| Hashitani, T; Hattori, S; Matsui, N; Nishino, H | 1 |
| Brannock, C; Cadet, JL | 1 |
| Hashitani, T; Kumazaki, M; Mizukawa, K; Nishino, H | 1 |
| Kamei, J; Morita, K; Saitoh, A; Sodeyama, M | 1 |
| Ishida, Y; Ishizuka, Y; Kuwahara, I; Mitsuyama, Y; Nakane, H; Nishimori, T; Todaka, K | 1 |
| Hashiguchi, H; Ishida, Y; Ishizuka, Y; Kuwahara, I; Mitsuyama, Y; Nakane, H; Todaka, K | 1 |
| Huang, J; Kita, T; Lowndes, HE; Philbert, MA; Wagner, GC | 1 |
| Hashiguchi, H; Ishida, Y; Ishizuka, Y; Kuwahara, I; Mitsuyama, Y; Nishimori, T; Todaka, K | 1 |
| Carter, RJ; Morton, AJ; Reynolds, DS | 1 |
| Atobe, J; Chikuma, T; Chuma, T; Kato, M; Miyatake, T; Shigenaga, T; Taguchi, K | 1 |
| Green, S; Jakowec, MW; Petzinger, GM; Tolwani, RJ; Waggie, K | 1 |
| Farrell, T; Kellaghan, P; Meredith, GE; Tan, Y; Totterdell, S; Zahm, DS | 1 |
| Camp, DM; LeWitt, PA; Loeffler, DA | 1 |
| Baba, H; Hida, H; Kumazaki, M; Nakajima, K; Nishino, H; Takei, N | 1 |
| Bell, KP; Choi, PK; Clarkson, ED; Esplen, JE; Freed, CR; Heidenreich, KA; Zawada, WM | 1 |
| Cadet, JL | 1 |
| Hashiguchi, H; Ishida, Y; Mitsuyama, Y; Nishimori, T; Takeda, R; Todaka, K | 1 |
| Bell, KP; Bjugstad, KB; Clarkson, ED; Freed, CR; Hutt, C; Marrack, P; Veng, LM; Zawada, WM | 1 |
| Chang, YC; Cherng, CF; Kuo, YM; Liao, PC; Lin, C; Yu, L | 1 |
| Gall, CM; Hess, US; Lynch, G; Sandoval, LM; Whalen, SP | 1 |
| Chen, GJ; Chou, J; Harvey, BK; Hoffer, BJ; Mark, A; Wang, Y | 1 |
| Ishido, M; Masuo, Y; Morita, M; Niki, E; Oka, S | 1 |
| Bannai, M; Kondoh, T; Nishino, H; Torii, K | 1 |
| Hayashi, K; Inden, M; Inoue, K; Kim, DH; Kitamura, Y; Nishimura, K; Qi, M; Shimohama, S; Sumi, S; Takata, K; Taniguchi, T; Tsuchiya, D; Yanagisawa, D; Yoshimoto, K | 1 |
| Abe, H; Hashiguchi, H; Ishida, Y; Kawai, K; Magata, Y; Mukai, T; Saji, H; Takeda, R; Yoshimoto, M | 1 |
| Ando, K; Higuchi, M; Inaji, M; Maeda, J; Nagai, Y; Nariai, T; Obayashi, S; Ohno, K; Okano, H; Okauchi, T; Suhara, T; Yoshizaki, T | 1 |
| Curtis, WR; Palmiter, RD; Perez, FA | 1 |
| Akita, H; Hoka, S; Jitsuki, S; Ogata, M; Ogura, T; Oh-Nishi, A; Saji, M | 1 |
| Aceves, J; Anaya-Martínez, V; Bannon, MJ; Flores, G; Garcia-Villegas, R; Gonzalez-Barrios, JA; Jiménez, I; Lindahl, M; Martinez-Arguelles, DB; Martinez-Fong, D; Navarro-Quiroga, I; Segovia, J; Trudeau, LE | 1 |
| Blake, BL; Breese, GR; Devine, DP; Egami, K; Jinnah, HA; Muehlmann, AM | 1 |
| Bruno, V; Busceti, CL; Falleni, A; Ferrucci, M; Fornai, F; Lazzeri, G; Lenzi, P; Paparelli, A | 1 |
| Ishido, M; Masuo, Y; Morita, M; Nagashima, K; Niki, E; Sawa, H | 1 |
| Fukakusa, A; Hayase, M; Ito, M; Kim, HC; Kumagai, N; Mizoguchi, H; Nabeshima, T; Nagai, T; Otsuka, N; Sato, K; Takuma, K; Yamada, K | 1 |
| Baucum, AJ; Cook, GA; Fleckenstein, AE; Gibb, JW; Hadlock, GC; Hanson, GR; Horner, KA; King, JL; Wilkins, DG | 1 |
| Fu, Y; Fujita, Y; Hirayama, M; Ichihara, M; Ito, M; Kajita, Y; Maesawa, S; Masuda, A; Ohno, K; Ohsawa, I; Ohta, S; Suzuki, Y | 1 |
| Duenas, VJ; Garzon-Muvdi, T; Mahajan, R; Quiñones-Hinojosa, A; Shah, A | 1 |
| Baes, M; Juri, C; Rubio, FJ; Somoza, R; Wyneken, U | 1 |
| Akamine, S; Fang, X; Namba, H; Sugiyama, K; Sun, W | 1 |
| Becker, KG; Brannock, C; Cadet, JL; Chou, J; Krasnova, IN; Ladenheim, B; Lehrmann, E; McCoy, MT; Wang, Y; Wood, WH | 1 |
| Daberkow, DP; Garris, PA; Howard, CD; Keefe, KA | 1 |
| El Ayadi, A; Zigmond, MJ | 1 |
| Blesa, J; Jackson-Lewis, V; Przedborski, S | 1 |
| Masuo, Y; Rakwal, R; Shibato, J | 1 |
| Napier, TC; Riddle, JL; Rokosik, SL | 1 |
| Martínez-Alonso, E; Martínez-Martínez, N; Martínez-Menárguez, JA; Rendón, WO; Tomás, M | 1 |
| Asakawa, T; Ito-Yamashita, T; Namba, H; Sugiyama, K; Sun, W | 1 |
| Jenner, P; Kadowaki Horita, T; Kanda, T; Kobayashi, M; Mori, A | 1 |
| Gupta, SP; Mishra, SK; Singh, MP; Singhal, NK; Tiwari, MN; Yadav, S | 1 |
| Dagda, RK; Das Banerjee, T; Janda, E | 1 |
| Hisahara, S; Honmou, O; Iwahara, N; Kawamata, J; Matsumura, A; Matsushita, T; Sasaki, M; Shimohama, S; Suzuki, S | 1 |
| Báez-Cordero, A; Caballero-Florán, R; Florán, B; González-Hernández, B; Limón, ID; Muñoz-Arenas, G; Paz-Bermúdez, F | 1 |
| Akita, H; Ishibashi, H; Noda, K; Ogata, M | 1 |
| Grill, WM; McConnell, GC; So, RQ | 1 |
| Doi, D; Murayama, S; Nishimura, K; Onoe, H; Samata, B; Tahara, T; Takahashi, J | 1 |
| Baldwin, HA; Harvey, BK; Koivula, PP; Necarsulmer, JC; Whitaker, KW | 1 |
| Ago, Y; Hasebe, S; Hashimoto, H; Imoto, E; Matsuda, T; Takuma, K; Tanaka, T; Umehara, C | 1 |
| Hida, H; Imamura, A; Ishida, A; Jung, CG; Marumoto, R; Shimizu, T; Ueda, Y | 1 |
| Ando, K; Inoue, R; Kawai, K; Nishime, C; Nishinaka, E; Tsutsumi, H; Urano, K | 1 |
| Akita, H; Ishibashi, H; Ogata, M | 1 |
8 review(s) available for methamphetamine and oxidopamine
| Article | Year |
|---|---|
Compensatory changes in striatal dopamine neurons following recovery from injury induced by 6-OHDA or methamphetamine: a review of evidence from microdialysis studies.
Topics: Animals; Corpus Striatum; Dopamine; Hydroxydopamines; Methamphetamine; Nerve Regeneration; Neuronal Plasticity; Neurons; Oxidopamine; Rats; Receptors, Dopamine | 1990 |
Free radicals and the pathobiology of brain dopamine systems.
Topics: Animals; Brain; Dopamine; Free Radicals; Humans; Methamphetamine; N-Methyl-3,4-methylenedioxyamphetamine; Neurodegenerative Diseases; Oxidopamine; Parkinson Disease; Reactive Oxygen Species | 1998 |
Experimental models of Parkinson's disease: insights from many models.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Disease Models, Animal; Dopamine; Humans; Methamphetamine; Oxidopamine; Parkinson Disease; Parkinson Disease, Secondary; Reserpine | 1999 |
Molecular neurotoxicological models of Parkinsonism: focus on genetic manipulation of mice.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Dopamine Agents; Humans; Methamphetamine; Mice; Mice, Knockout; Mice, Transgenic; Neurotoxins; Oxidopamine; Parkinsonian Disorders | 2001 |
Animal models of neurological disease.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Adrenergic Agents; Amyloid beta-Protein Precursor; Animals; Antipsychotic Agents; Brain Ischemia; Central Nervous System; Central Nervous System Stimulants; Disease Models, Animal; Humans; Methamphetamine; Nervous System Diseases; Neurotoxins; Oxidopamine; Reserpine; Rotenone; Uncoupling Agents | 2010 |
Animal models of Parkinson's disease.
Topics: Animals; Disease Models, Animal; Humans; Insecticides; Methamphetamine; MPTP Poisoning; Oxidopamine; Parkinson Disease | 2012 |
Does restraining nitric oxide biosynthesis rescue from toxins-induced parkinsonism and sporadic Parkinson's disease?
Topics: Animals; Humans; Methamphetamine; Nitric Oxide; Nitric Oxide Synthase; Oxidative Stress; Oxidopamine; Parkinson Disease, Secondary; Parkinsonian Disorders; Reactive Nitrogen Species; Rotenone | 2014 |
How Parkinsonian toxins dysregulate the autophagy machinery.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Autophagy; Humans; Methamphetamine; Mitophagy; MPTP Poisoning; Neurotoxins; Oxidopamine; Paraquat; Parkinsonian Disorders; Rotenone | 2013 |
93 other study(ies) available for methamphetamine and oxidopamine
| Article | Year |
|---|---|
Behavioral and biochemical effects of a novel calcium antagonist, KB-2796, on the central dopaminergic system.
Topics: Animals; Apomorphine; Behavior, Animal; Biogenic Monoamines; Brain; Brain Diseases; Calcium Channel Blockers; Corpus Striatum; Dopamine; Locomotion; Male; Methamphetamine; Mice; Oxidopamine; Piperazines | 1991 |
2-phenylethylamine and methamphetamine enhance the spinal monosynaptic reflex by releasing noradrenaline from the terminals of descending fibers.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Animals; Blood Pressure; Hydroxydopamines; Male; Methamphetamine; Monoamine Oxidase Inhibitors; Nerve Endings; Neurons; Norepinephrine; Oxidopamine; Phenethylamines; Prazosin; Psychotropic Drugs; Rats; Rats, Inbred Strains; Receptors, Dopamine; Receptors, Dopamine D1; Receptors, Dopamine D2; Reflex, Monosynaptic; Reserpine; Spinal Cord | 1991 |
Effect of intra-amygdala dopaminergic grafts on methamphetamine-induced locomotor activity, extracellular dopamine and dopamine metabolite overflow: a comparison with the effect of intra-accumbens grafts.
Topics: 3,4-Dihydroxyphenylacetic Acid; Amygdala; Animals; Brain Tissue Transplantation; Dopamine; Electrophysiology; Homovanillic Acid; Hydroxydopamines; Male; Methamphetamine; Motor Activity; Nucleus Accumbens; Oxidopamine; Rats; Rats, Inbred Strains | 1991 |
Long-term survival of grafted cells, dopamine synthesis/release, synaptic connections, and functional recovery after transplantation of fetal nigral cells in rats with unilateral 6-OHDA lesions in the nigrostriatal dopamine pathway.
Topics: Animals; Brain; Brain Tissue Transplantation; Catecholamines; Caudate Nucleus; Cell Survival; Corpus Striatum; Dendrites; Dopamine; Female; Fetal Tissue Transplantation; Hydroxydopamines; Methamphetamine; Microscopy, Electron; Motor Activity; Neurotoxins; Oxidopamine; Rats; Rats, Inbred Strains; Substantia Nigra; Synapses; Tyrosine 3-Monooxygenase | 1990 |
Behavioral and biochemical effects of intra-accumbens dopaminergic grafts.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Dopamine; Graft Survival; Hydroxydopamines; Male; Mesencephalon; Methamphetamine; Motor Activity; Neurotoxins; Nucleus Accumbens; Oxidopamine; Rats; Rats, Inbred Strains; Septal Nuclei | 1990 |
Pargyline increases 6-hydroxydopamine levels in the neostriatum of methamphetamine-treated rats.
Topics: Animals; Corpus Striatum; Drug Synergism; Hydroxydopamines; Male; Methamphetamine; Oxidopamine; Pargyline; Rats; Rats, Inbred Strains | 1990 |
Unilateral dopamine depletion causes bilateral deficits in conditioned rotation in rats.
Topics: Animals; Brain; Conditioning, Operant; Corpus Striatum; Dopamine; Functional Laterality; Hydroxydopamines; Male; Methamphetamine; Motor Activity; Oxidopamine; Rats; Rats, Inbred Strains; Substantia Nigra | 1990 |
alpha-Methyl-p-tyrosine pretreatment partially prevents methamphetamine-induced endogenous neurotoxin formation.
Topics: 5,6-Dihydroxytryptamine; alpha-Methyltyrosine; Animals; Brain; Dopamine; Hydroxydopamines; Male; Methamphetamine; Methyltyrosines; Neurotoxins; Oxidopamine; Rats; Rats, Inbred Strains | 1990 |
Dopamine uptake inhibitors block long-term neurotoxic effects of methamphetamine upon dopaminergic neurons.
Topics: Animals; Corpus Striatum; Dopamine; Hydroxydopamines; Indoles; Male; Mazindol; Methamphetamine; Nalidixic Acid; Naphthyridines; Neurotoxins; Neurotransmitter Uptake Inhibitors; Oxidopamine; Rats; Rats, Inbred Strains; Serotonin | 1990 |
The effects of monoamine uptake inhibitors and methamphetamine on neostriatal 6-hydroxydopamine (6-OHDA) formation, short-term monoamine depletions and locomotor activity in the rat.
Topics: Animals; Brain; Dopamine; Hydroxydopamines; Male; Mazindol; Methamphetamine; Motor Activity; Nalidixic Acid; Naphthyridines; Neurotransmitter Uptake Inhibitors; Oxidopamine; Rats; Rats, Inbred Strains; Serotonin | 1990 |
Nigrostriatal dopamine actions on the D2 receptors mediate methamphetamine effects on the striatonigral substance P system.
Topics: 5,7-Dihydroxytryptamine; alpha-Methyltyrosine; Animals; Corpus Striatum; Dopamine; Hydroxydopamines; Levodopa; Male; Methamphetamine; Methyltyrosines; Oxidopamine; Rats; Rats, Inbred Strains; Substance P; Substantia Nigra; Synaptic Transmission; Tryptophan Hydroxylase | 1986 |
Nimodipine enhances growth and vascularization of neural grafts.
Topics: Animals; Dopamine; Female; Gestational Age; Graft Survival; Hydroxydopamines; Mesencephalon; Methamphetamine; Motor Activity; Neovascularization, Pathologic; Nimodipine; Oxidopamine; Rats; Rats, Inbred Strains; Substantia Nigra; Tegmentum Mesencephali | 1989 |
Neonatal dopamine-rich grafts and 6-OHDA lesions independently provide partial protection from the adult nigrostriatal lesion syndrome.
Topics: Animals; Apomorphine; Corpus Striatum; Dominance, Cerebral; Dopamine; Haloperidol; Hydroxydopamines; Male; Mesencephalon; Methamphetamine; Motor Activity; Motor Skills; Nerve Regeneration; Oxidopamine; Rats; Rats, Inbred Strains; Receptors, Dopamine; Substantia Nigra | 1989 |
Comparison of adrenal and foetal nigral grafts on drug-induced rotation in rats with 6-OHDA lesions.
Topics: Adrenal Medulla; Animals; Apomorphine; Cell Separation; Corpus Striatum; Embryo, Mammalian; Female; Hydroxydopamines; Methamphetamine; Oxidopamine; Rats; Rats, Inbred Strains; Stereotyped Behavior; Substantia Nigra | 1989 |
Methamphetamine: toxicity to dopaminergic neurons.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Brain Chemistry; Dopamine; Guinea Pigs; Hydroxydopamines; Kinetics; Macaca mulatta; Methamphetamine; Mice; Nerve Endings; Neurons; Neurotransmitter Agents; Norepinephrine; Oxidopamine; Rats; Receptors, Dopamine; Serotonin; Spiperone; Substance-Related Disorders | 1985 |
[Neuroleptic properties of Y-516, a new iminodibenzyl derivative].
Topics: Animals; Antipsychotic Agents; Apomorphine; Benzazepines; Corpus Striatum; Dogs; Female; Hydroxydopamines; Hypothalamic Area, Lateral; Hypothermia, Induced; Male; Methamphetamine; Mice; Motor Activity; Oxidopamine; Rats; Rats, Inbred Strains; Receptors, Dopamine; Self Stimulation; Vomiting | 1985 |
Role of the dopaminergic nigrostriatal pathway in methamphetamine-induced depression of the neostriatal serotonergic system.
Topics: Animals; Corpus Striatum; Depression, Chemical; Hydroxydopamines; Male; Methamphetamine; Oxidopamine; Rats; Rats, Inbred Strains; Receptors, Dopamine; Serotonin; Substantia Nigra; Tryptophan Hydroxylase; Tyrosine 3-Monooxygenase | 1987 |
Adrenal medullary cells transmute into dopaminergic neurons in dopamine-depleted rat caudate and ameliorate motor disturbances.
Topics: Adrenal Medulla; Animals; Animals, Newborn; Axons; Caudate Nucleus; Dopamine; Female; Histocytochemistry; Hydroxydopamines; Methamphetamine; Microscopy, Electron; Motor Activity; Neurons; Oxidopamine; Rats; Synapses; Tyrosine 3-Monooxygenase | 1988 |
Graft-derived recovery from 6-OHDA lesions: specificity of ventral mesencephalic graft tissues.
Topics: Acetylcholinesterase; Animals; Corpus Striatum; Dopamine; Female; Hydroxydopamines; Methamphetamine; Oxidopamine; Rats; Rats, Inbred Strains; Stereotyped Behavior; Substantia Nigra; Tyrosine 3-Monooxygenase | 1988 |
Characterization of methamphetamine effects on the striatal-nigral dynorphin system.
Topics: 3,4-Methylenedioxyamphetamine; Animals; Corpus Striatum; Dynorphins; Hydroxydopamines; Male; Methamphetamine; N-Methyl-3,4-methylenedioxyamphetamine; Oxidopamine; Radioimmunoassay; Rats; Rats, Inbred Strains; Substantia Nigra; Sympathectomy, Chemical | 1988 |
delta 9-Tetrahydrocannabinol elicited ipsilateral circling behavior in rats with unilateral nigral lesion.
Topics: Animals; Apomorphine; Behavior, Animal; Dopamine; Dronabinol; Haloperidol; Hydroxydopamines; Male; Methamphetamine; Neurons; Oxidopamine; Rats; Rats, Inbred Strains; Substantia Nigra | 1985 |
Transplants in the peri- and intraventricular region grow better than those in the central parenchyma of the caudate.
Topics: Animals; Brain Diseases; Corpus Striatum; Dopamine; Hydroxydopamines; Mesencephalon; Methamphetamine; Movement Disorders; Neural Pathways; Oxidopamine; Rats; Substantia Nigra | 1986 |
Methamphetamine-induced behavioral alterations following repeated administration of methamphetamine.
Topics: Animals; Brain Chemistry; Catecholamines; Corpus Striatum; Drug Interactions; Haloperidol; Hydroxydopamines; Injections; Male; Methamphetamine; Methotrimeprazine; Mice; Motor Activity; Oxidopamine; Stereotyped Behavior | 1986 |
Dopamine-rich grafts ameliorate whole body motor asymmetry and sensory neglect but not independent limb use in rats with 6-hydroxydopamine lesions.
Topics: Animals; Apomorphine; Corpus Striatum; Dopamine; Female; Forelimb; Functional Laterality; Hydroxydopamines; Mesencephalon; Methamphetamine; Motor Skills; Oxidopamine; Rats; Rats, Inbred Strains; Stereotyped Behavior; Substantia Nigra | 1987 |
[Functional improvement produced by transplantation of fetal neuronal cell suspensions in the rat striatum with 6-hydroxydopamine lesions].
Topics: Animals; Apomorphine; Catecholamines; Corpus Striatum; Dopamine; Female; Hydroxydopamines; Methamphetamine; Motor Activity; Neurons; Oxidopamine; Rats; Rats, Inbred Strains; Rotation | 1987 |
Altered responding to cholecystokinins and dopaminergic agonists following 6-hydroxydopamine treatment in rats.
Topics: Animals; Apomorphine; Brain; Dopamine; Gastrins; Hydroxydopamines; Male; Methamphetamine; Motor Activity; Oxidopamine; Proglumide; Rats; Rats, Inbred Strains; Sincalide; Tetragastrin | 1985 |
Irritable aggression induced by delta 9-tetrahydrocannabinol in rats pretreated with 6-hydroxydopamine.
Topics: Aggression; Animals; Apomorphine; Catecholamines; Dopamine; Dronabinol; Humans; Hydroxydopamines; Male; Methamphetamine; Norepinephrine; Oxidopamine; Rats; Rats, Inbred Strains; Serotonin; Time Factors | 1984 |
Effect of methamphetamine on the locomotor activity in the 6-OHDA dorsal hippocampus lesioned rat.
Topics: Animals; Behavior, Animal; Dopamine; Dose-Response Relationship, Drug; Hippocampus; Hydroxydopamines; Male; Methamphetamine; Motor Activity; Norepinephrine; Oxidopamine; Rats; Rats, Inbred Strains; Serotonin; Sympathectomy, Chemical | 1984 |
Formation of 6-hydroxydopamine in caudate nucleus of the rat brain after a single large dose of methylamphetamine.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Caudate Nucleus; Dopamine; Hydroxydopamines; Male; Methamphetamine; Nervous System Diseases; Oxidopamine; Rats; Rats, Inbred Strains | 1984 |
Decreased sensitivity of rat pups to long-lasting dopamine and serotonin depletions produced by methylamphetamine.
Topics: Animals; Animals, Newborn; Brain Chemistry; Caudate Nucleus; Dopamine; Hydroxydopamines; Mesencephalon; Methamphetamine; Oxidopamine; Rats; Rats, Inbred Strains; Serotonin; Telencephalon | 1982 |
Effects of pargyline and pyrogallol on the methamphetamine-induced dopamine depletion.
Topics: 3,4-Dihydroxyphenylacetic Acid; Analysis of Variance; Animals; Chromatography, High Pressure Liquid; Corpus Striatum; Dopamine; Male; Methamphetamine; Oxidopamine; Pargyline; Pyrogallol; Rats; Rats, Sprague-Dawley; Reference Values; Time Factors | 1995 |
Cholecystokinin facilitates methamphetamine-induced dopamine overflow in rat striatum and fetal ventral mesencephalic grafts.
Topics: Animals; Caudate Nucleus; Cholecystokinin; Corpus Striatum; Dopamine; Drug Synergism; Electrochemistry; Fetal Tissue Transplantation; Medial Forebrain Bundle; Mesencephalon; Methamphetamine; Oxidopamine; Rats; Rats, Sprague-Dawley; Reference Values | 1994 |
SKF-10,047 reverses stress-induced motor suppression: interaction with dopaminergic system.
Topics: 8-Hydroxy-2-(di-n-propylamino)tetralin; Animals; Anti-Anxiety Agents; Anticonvulsants; Apomorphine; Dopamine; Electroshock; Guanidines; Male; Methamphetamine; Mice; Mice, Inbred Strains; Motor Activity; Oxidopamine; Pentazocine; Phenazocine; Pimozide; Pyrimidines; Receptors, sigma; Stress, Psychological | 1994 |
[Rotational behavior induced by methamphetamine and cocaine in rats with unilateral 6-hydroxydopamine lesions of the nigrostriatal dopamine system].
Topics: Animals; Behavior, Animal; Cocaine; Corpus Striatum; Male; Methamphetamine; Motor Activity; Oxidopamine; Rats; Rats, Sprague-Dawley; Receptors, Dopamine; Synaptic Transmission | 1994 |
Appearance of EMG activity and motor asymmetry after unilateral lesions of the dopaminergic innervation to the subthalamic nucleus in the rat.
Topics: Animals; Bicuculline; Dopamine; Electromyography; gamma-Aminobutyric Acid; Male; Methamphetamine; Motor Activity; Muscle Rigidity; Oxidopamine; Rats; Rats, Wistar; Stereotyped Behavior; Synaptic Transmission; Thalamic Nuclei | 1993 |
Methamphetamine antagonistic property of (+)- and (-)-4-phenyltetrahydroisoquinoline in rat anococcygeus muscle.
Topics: Animals; Cocaine; Electric Stimulation; In Vitro Techniques; Isoquinolines; Male; Methamphetamine; Methoxamine; Muscle Contraction; Muscles; Nerve Endings; Nomifensine; Norepinephrine; Oxidopamine; Rats; Rats, Wistar; Stereoisomerism; Tetrahydroisoquinolines | 1993 |
Short-term effects of 2,4,5-trihydroxyamphetamine, 2,4,5-trihydroxymethamphetamine and 3,4-dihydroxymethamphetamine on central tryptophan hydroxylase activity.
Topics: 5,6-Dihydroxytryptamine; Amphetamines; Animals; Corpus Striatum; Deoxyepinephrine; Enzyme Activation; Hippocampus; In Vitro Techniques; Male; Methamphetamine; Oxidopamine; Rats; Rats, Sprague-Dawley; Tryptophan Hydroxylase | 1993 |
Roles of dopamine D1 receptors in striatal fos protein induction associated with methamphetamine behavioral sensitization in rats.
Topics: Animals; Behavior, Animal; Dopamine Agents; Dopamine Antagonists; Dopamine D2 Receptor Antagonists; Immunohistochemistry; Male; Methamphetamine; Neostriatum; Oxidopamine; Proto-Oncogene Proteins c-fos; Rats; Rats, Wistar; Receptors, Dopamine D1; Rotation; Stereotyped Behavior | 1995 |
Uridine reduces rotation induced by L-dopa and methamphetamine in 6-OHDA-treated rats.
Topics: Animals; Behavior, Animal; Dose-Response Relationship, Drug; Haloperidol; Levodopa; Male; Methamphetamine; Oxidopamine; Rats; Rats, Sprague-Dawley; Rotation; Uridine | 1995 |
Characterization and transplantation of two neuronal cell lines with dopaminergic properties.
Topics: 3,4-Dihydroxyphenylacetic Acid; Adenylyl Cyclases; Animals; Bucladesine; Butyrates; Butyric Acid; Carrier Proteins; Cell Differentiation; Cell Line, Transformed; Cell Transplantation; Clone Cells; Cyclic AMP; Dopamine; Dopamine Plasma Membrane Transport Proteins; Intermediate Filament Proteins; Isoenzymes; Kinetics; Male; Membrane Glycoproteins; Membrane Transport Proteins; Mesencephalon; Methamphetamine; Mice; Nerve Tissue Proteins; Nestin; Neuroblastoma; Neurons; Oxidopamine; Phosphopyruvate Hydratase; Protein Kinase C; Protein Kinase C beta; Protein Kinase C-delta; Rats; Rats, Sprague-Dawley; Receptors, Adrenergic, alpha; Receptors, Adrenergic, beta; Stereotyped Behavior; Tyrosine 3-Monooxygenase | 1996 |
Dopaminergic transplants suppress L-DOPA-induced Fos expression in the dopamine-depleted striatum in a rat model of Parkinson's disease.
Topics: Animals; Brain Tissue Transplantation; Caudate Nucleus; Corpus Striatum; Dizocilpine Maleate; Dopamine; Female; Fetal Tissue Transplantation; Levodopa; Mesencephalon; Methamphetamine; Motor Activity; Oxidopamine; Parkinson Disease, Secondary; Proto-Oncogene Proteins c-fos; Putamen; Rats; Rats, Wistar; Tyrosine 3-Monooxygenase | 1996 |
Dynamic regulation of striatal dopaminergic grafts during locomotor activity.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Cell Transplantation; Corpus Striatum; Dopamine; Extracellular Space; Homovanillic Acid; Methamphetamine; Microdialysis; Motor Activity; Oxidopamine; Parkinson Disease, Secondary; Rats; Rats, Wistar; Rotation; Stereotyped Behavior; Substantia Nigra; Time Factors | 1996 |
Dopamine metabolism in the striatum of hemiparkinsonian model rats with dopaminergic grafts.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Autoradiography; Brain Tissue Transplantation; Carrier Proteins; Corpus Striatum; Dopamine; Dopamine Plasma Membrane Transport Proteins; Female; Fetal Tissue Transplantation; Functional Laterality; Haloperidol; Homovanillic Acid; Kinetics; Levodopa; Mazindol; Membrane Glycoproteins; Membrane Transport Proteins; Mesencephalon; Methamphetamine; Microdialysis; Motor Activity; Nerve Tissue Proteins; Oxidopamine; Parkinson Disease, Secondary; Rats; Rats, Wistar; Rotation; Tritium; Tyrosine 3-Monooxygenase | 1998 |
Effects of the experimental diabetes on dopamine D1 receptor-mediated locomotor-enhancing activity in mice.
Topics: Animals; Benzazepines; Brain; Cocaine; Diabetes Mellitus, Experimental; Dopamine Agonists; Dopamine Antagonists; Dopamine Uptake Inhibitors; Male; Methamphetamine; Mice; Mice, Inbred ICR; Motor Activity; Oxidopamine; Receptors, Dopamine D1 | 1998 |
Methamphetamine-induced Fos expression in the substantia nigra pars reticulata in rats with a unilateral 6-OHDA lesion of the nigrostriatal fibers.
Topics: Animals; Dizocilpine Maleate; Excitatory Amino Acid Antagonists; Female; Methamphetamine; Nerve Fibers; Oxidopamine; Proto-Oncogene Proteins c-fos; Rats; Rats, Wistar; Substantia Nigra; Sympatholytics; Sympathomimetics; Tyrosine 3-Monooxygenase | 1998 |
Peripherally administered tetrahydrobiopterin increases in vivo tryptophan hydroxylase activity in the striatum after transplantation of fetal ventral mesencephalon in six hydroxydopamine lesioned rats.
Topics: 5-Hydroxytryptophan; Animals; Antioxidants; Biopterins; Brain Tissue Transplantation; Corpus Striatum; Denervation; Embryo, Mammalian; Female; Fetal Tissue Transplantation; Functional Laterality; Injections, Intraperitoneal; Mesencephalon; Methamphetamine; Microdialysis; Motor Activity; Oxidopamine; Prosencephalon; Rats; Rats, Wistar; Rotation; Tryptophan Hydroxylase | 1998 |
Methamphetamine-induced modification of dopamine metabolism in cultured striatal astrocytes.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Animals, Newborn; Astrocytes; Cells, Cultured; Corpus Striatum; Dopamine; Dopamine Uptake Inhibitors; Dose-Response Relationship, Drug; Methamphetamine; Monoamine Oxidase Inhibitors; Oxidopamine; Rats; Rats, Sprague-Dawley | 1998 |
Methamphetamine induces fos expression in the striatum and the substantia nigra pars reticulata in a rat model of Parkinson's disease.
Topics: Animals; Behavior, Animal; Benzazepines; Brain Chemistry; Brain Tissue Transplantation; Corpus Striatum; Disease Models, Animal; Dizocilpine Maleate; Dopamine Agents; Dopamine Antagonists; Excitatory Amino Acid Antagonists; Female; Mesencephalon; Methamphetamine; Neurons; Oxidopamine; Parkinson Disease, Secondary; Proto-Oncogene Proteins c-fos; Raclopride; Rats; Rats, Wistar; Receptors, Dopamine D1; Receptors, Dopamine D2; Rotation; Salicylamides; Substantia Nigra; Sympatholytics; Tyrosine 3-Monooxygenase | 1998 |
Dopamine modulates the susceptibility of striatal neurons to 3-nitropropionic acid in the rat model of Huntington's disease.
Topics: Animals; Antihypertensive Agents; Behavior, Animal; Benzazepines; Corpus Striatum; Disease Models, Animal; Dopamine; Dopamine Antagonists; Drug Interactions; Female; Huntington Disease; Methamphetamine; Microglia; Nerve Degeneration; Neurons; Nitro Compounds; Oxidopamine; Propionates; Rats; Rats, Sprague-Dawley; Substantia Nigra; Sympatholytics; Sympathomimetics | 1998 |
The effect of methamphetamine on the release of acetylcholine in the rat striatum.
Topics: Acetylcholine; Adrenergic Agents; Adrenergic Uptake Inhibitors; alpha-Methyltyrosine; Animals; Apomorphine; Corpus Striatum; Dopamine Agonists; Dopamine Uptake Inhibitors; Enzyme Inhibitors; Male; Methamphetamine; Microdialysis; Oxidopamine; Rats; Rats, Wistar; Reserpine; Tetrodotoxin | 1998 |
Immunocytochemical characterization of catecholaminergic neurons in the rat striatum following dopamine-depleting lesions.
Topics: Animals; Aromatic-L-Amino-Acid Decarboxylases; Cell Count; Corpus Striatum; Denervation; Dopamine; Immunohistochemistry; Male; Methamphetamine; Microscopy, Electron; Nerve Fibers; Neurons; Nucleus Accumbens; Oxidopamine; Rats; Rats, Sprague-Dawley; Sympatholytics; Tyrosine 3-Monooxygenase | 1999 |
L-DOPA does not enhance hydroxyl radical formation in the nigrostriatal dopamine system of rats with a unilateral 6-hydroxydopamine lesion.
Topics: Animals; Cerebellum; Corpus Striatum; Gentisates; Hydroxybenzoates; Hydroxyl Radical; Injections; Levodopa; Male; Mesencephalon; Methamphetamine; Microdialysis; Osmolar Concentration; Oxidopamine; Rats; Rats, Sprague-Dawley; Salicylates; Substantia Nigra | 2000 |
Mesencephalic neural stem (progenitor) cells develop to dopaminergic neurons more strongly in dopamine-depleted striatum than in intact striatum.
Topics: Animals; Cell Count; Cell Culture Techniques; Cell Differentiation; Cell Division; Cell Survival; Corpus Striatum; Dopamine; Female; Glial Fibrillary Acidic Protein; Graft Survival; Mesencephalon; Methamphetamine; Motor Activity; Neurites; Neurons; Oxidopamine; Rats; Rats, Wistar; Stem Cell Transplantation; Stem Cells; Substantia Nigra; Tyrosine 3-Monooxygenase | 2000 |
IGF-I and bFGF improve dopamine neuron survival and behavioral outcome in parkinsonian rats receiving cultured human fetal tissue strands.
Topics: Abortion, Induced; Animals; Apomorphine; Brain; Brain Tissue Transplantation; Cell Survival; Cells, Cultured; Disease Models, Animal; Dopamine; Female; Fetal Tissue Transplantation; Fibroblast Growth Factor 2; Homovanillic Acid; Humans; Insulin-Like Growth Factor I; Male; Methamphetamine; Motor Activity; Neurons; Oxidopamine; Parkinsonian Disorders; Pregnancy; Rats; Rats, Sprague-Dawley; Rotation; Transplantation, Heterologous; Tyrosine 3-Monooxygenase | 2001 |
Morphological changes in immunopositive cells of ionotropic glutamate receptor subunits during the development of transplanted fetal ventral mesencephalic neurons.
Topics: Animals; Behavior, Animal; Brain Tissue Transplantation; Cell Differentiation; Disease Models, Animal; Female; Fetal Tissue Transplantation; Graft Survival; Immunohistochemistry; Mesencephalon; Methamphetamine; Neurons; Oxidopamine; Parkinsonian Disorders; Rats; Rats, Wistar; Receptors, Glutamate; Receptors, N-Methyl-D-Aspartate; Tyrosine 3-Monooxygenase | 2002 |
Xenografts of MHC-deficient mouse embryonic mesencephalon improve behavioral recovery in hemiparkinsonian rats.
Topics: Animals; Behavior, Animal; Corpus Striatum; Dopamine; Histocompatibility Antigens Class II; Immunohistochemistry; Major Histocompatibility Complex; Male; Mesencephalon; Methamphetamine; Mice; Mice, Inbred C57BL; Mice, Knockout; Mice, Transgenic; Neurons; Oxidopamine; Parkinson Disease; Rats; Rats, Sprague-Dawley; Recovery of Function; Sympatholytics; Time Factors; Transplantation, Heterologous; Transplantation, Heterotopic; Tyrosine 3-Monooxygenase | 2002 |
Striatal formation of 6-hydroxydopamine in mice treated with pargyline, pyrogallol and methamphetamine.
Topics: Animals; Catechol O-Methyltransferase Inhibitors; Chromatography, High Pressure Liquid; Corpus Striatum; Dopamine Agents; Female; Methamphetamine; Mice; Mice, Inbred C57BL; Monoamine Oxidase Inhibitors; Oxidopamine; Pargyline; Pyrogallol; Spectrometry, Mass, Electrospray Ionization; Sympatholytics | 2003 |
Ampakines reduce methamphetamine-driven rotation and activate neocortex in a regionally selective fashion.
Topics: Adrenergic Agents; Animals; Autoradiography; Behavior, Animal; Cell Count; Central Nervous System Stimulants; Cerebral Cortex; Dioxoles; Dose-Response Relationship, Drug; Drug Interactions; Functional Laterality; Immunohistochemistry; In Situ Hybridization; Male; Methamphetamine; Neocortex; Oxazines; Oxidopamine; Piperidines; Proto-Oncogene Proteins c-fos; Rats; Rats, Sprague-Dawley; Receptors, AMPA; Rotation; Stereotyped Behavior; Substantia Nigra; Time Factors; Tyrosine 3-Monooxygenase | 2003 |
Neurotrophic effects of bone morphogenetic protein-7 in a rat model of Parkinson's disease.
Topics: Adrenergic Agents; Animals; Behavior, Animal; Bone Morphogenetic Protein 7; Bone Morphogenetic Proteins; Cell Count; Corpus Striatum; Disease Models, Animal; Dopamine; Dopamine Uptake Inhibitors; Dose-Response Relationship, Drug; Electrochemistry; Immunohistochemistry; Male; Methamphetamine; Nerve Growth Factors; Oxidopamine; Parkinson Disease; Potassium; Rats; Rats, Inbred F344; Tyrosine 3-Monooxygenase | 2004 |
Motor activity and gene expression in rats with neonatal 6-hydroxydopamine lesions.
Topics: Animals; Animals, Newborn; Brain Chemistry; Catecholamines; Central Nervous System Stimulants; Chromatography, High Pressure Liquid; Disease Models, Animal; Electrochemistry; Gene Expression; Gene Expression Regulation, Developmental; Hyperkinesis; Immunohistochemistry; Ion Channels; Male; Methamphetamine; Motor Activity; Neurons; Neuropeptides; Oligonucleotide Array Sequence Analysis; Oxidopamine; Rats; Receptors, Cell Surface; Tyrosine 3-Monooxygenase | 2004 |
6-Hydroxydopamine-induced lesions in a rat model of hemi-Parkinson's disease monitored by magnetic resonance imaging.
Topics: Animals; Brain; Disease Models, Animal; Dopamine; Dose-Response Relationship, Drug; Drug Interactions; Immunohistochemistry; Magnetic Resonance Imaging; Male; Methamphetamine; Neurotoxins; Oxidopamine; Parkinsonian Disorders; Predictive Value of Tests; Rats; Rats, Wistar; Rotation; Substantia Nigra; Tyrosine 3-Monooxygenase | 2005 |
Transplantation of mouse embryonic stem cell-derived neurons into the striatum, subthalamic nucleus and substantia nigra, and behavioral recovery in hemiparkinsonian rats.
Topics: Animals; Basal Ganglia; Behavior, Animal; Brain Tissue Transplantation; Cell Count; Corpus Striatum; Denervation; Disease Models, Animal; Graft Survival; Growth Cones; Hyperkinesis; Male; Methamphetamine; Mice; Neurons; Oxidopamine; Parkinsonian Disorders; Pluripotent Stem Cells; Rats; Rats, Wistar; Recovery of Function; Stem Cell Transplantation; Substantia Nigra; Subthalamic Nucleus | 2005 |
Alteration of striatal [11C]raclopride and 6-[18F]fluoro-L-3,4-dihydroxyphenylalanine uptake precedes development of methamphetamine-induced rotation following unilateral 6-hydroxydopamine lesions of medial forebrain bundle in rats.
Topics: Animals; Biological Transport; Carbon Radioisotopes; Dihydroxyphenylalanine; Fluorine Radioisotopes; Functional Laterality; Methamphetamine; Motor Activity; Oxidopamine; Prosencephalon; Raclopride; Radionuclide Imaging; Rats; Rotation; Tissue Distribution | 2005 |
Correlation between quantitative imaging and behavior in unilaterally 6-OHDA-lesioned rats.
Topics: Animals; Apomorphine; Autoradiography; Behavior, Animal; Dopamine; Dopamine Agents; Dopamine Plasma Membrane Transport Proteins; Dose-Response Relationship, Drug; Functional Laterality; Male; Methamphetamine; Movement; Neostriatum; Neurons; Oxidopamine; Parkinsonian Disorders; Positron-Emission Tomography; Rats; Rats, Sprague-Dawley; Receptors, Dopamine D2 | 2005 |
Parkin-deficient mice are not more sensitive to 6-hydroxydopamine or methamphetamine neurotoxicity.
Topics: Aging; Animals; Dopamine; Drug Resistance; Methamphetamine; Mice; Mice, Knockout; Nerve Degeneration; Neurons; Neurotoxins; Oxidative Stress; Oxidopamine; Ubiquitin; Ubiquitin-Protein Ligases | 2005 |
Nigral injection of antisense oligonucleotides to synaptotagmin I using HVJ-liposome vectors causes disruption of dopamine release in the striatum and impaired skill learning.
Topics: Analysis of Variance; Animals; Behavior, Animal; Corpus Striatum; Disease Models, Animal; Dopamine; Gene Transfer Techniques; Immunohistochemistry; Male; Methamphetamine; Microdialysis; Motor Activity; Motor Skills; Motor Skills Disorders; Oligonucleotides, Antisense; Oxidopamine; Rats; Rats, Wistar; Reaction Time; Rotarod Performance Test; Substantia Nigra; Synaptotagmin I | 2006 |
Neurotensin polyplex as an efficient carrier for delivering the human GDNF gene into nigral dopamine neurons of hemiparkinsonian rats.
Topics: Animals; Apomorphine; Corpus Striatum; Dopamine; Genetic Therapy; Genetic Vectors; Glial Cell Line-Derived Neurotrophic Factor; Humans; Immunohistochemistry; Methamphetamine; Nanoparticles; Neurons; Neurotensin; Oxidopamine; Parkinson Disease, Secondary; Rats; Substantia Nigra; Time Factors; Transfection | 2006 |
Nifedipine suppresses self-injurious behaviors in animals.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl ester; Animals; Behavior, Animal; Calcium Channel Agonists; Calcium Channel Blockers; Central Nervous System Stimulants; Disease Models, Animal; Female; Male; Methamphetamine; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Nifedipine; Oxidopamine; Pemoline; Pregnancy; Rats; Rats, Long-Evans; Rats, Sprague-Dawley; Self-Injurious Behavior; Sympatholytics | 2007 |
Mechanisms involved in the formation of dopamine-induced intracellular bodies within striatal neurons.
Topics: Adrenergic Agents; alpha-Synuclein; Analysis of Variance; Animals; Cells, Cultured; Corpus Striatum; Dopamine; Dopamine Uptake Inhibitors; Dose-Response Relationship, Drug; Drug Interactions; Inclusion Bodies; Male; Methamphetamine; Mice; Microscopy, Electron, Transmission; Neurons; Oxidopamine; Proteasome Endopeptidase Complex; Rats; Reactive Oxygen Species; Time Factors; Ubiquitin | 2007 |
Behavioural characteristics and gene expression in the hyperactive wiggling (Wig) rat.
Topics: Adrenergic Agents; Analysis of Variance; Animals; Animals, Congenic; Animals, Newborn; Behavior, Animal; Carrier Proteins; Central Nervous System Stimulants; Circadian Rhythm; GABA Plasma Membrane Transport Proteins; gamma-Aminobutyric Acid; Gene Expression; Gene Expression Profiling; Hyperkinesis; Mesencephalon; Methamphetamine; Oligonucleotide Array Sequence Analysis; Oxidopamine; Rats; Receptor, Adenosine A2A; Time Factors; Tyrosine 3-Monooxygenase | 2007 |
Activation of post-synaptic dopamine D₁ receptors promotes the release of tissue plasminogen activator in the nucleus accumbens via PKA signaling.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Analgesics, Opioid; Animals; Benzazepines; Brain Chemistry; Cyclic AMP-Dependent Protein Kinases; Dopamine Agonists; Dopamine Antagonists; Dopamine Uptake Inhibitors; Immunohistochemistry; Male; Methamphetamine; Mice; Mice, Inbred ICR; Morphine; Nucleus Accumbens; Oxidopamine; Protein Kinase Inhibitors; Raclopride; Receptors, Dopamine D1; Signal Transduction; Sympatholytics; Synapses; Tissue Plasminogen Activator; Tyrosine 3-Monooxygenase | 2007 |
Mechanisms underlying methamphetamine-induced dopamine transporter complex formation.
Topics: Animals; Benzazepines; Blotting, Western; Data Interpretation, Statistical; Dopamine; Dopamine Antagonists; Dopamine D2 Receptor Antagonists; Dopamine Plasma Membrane Transport Proteins; Dopamine Uptake Inhibitors; In Vitro Techniques; Male; Methamphetamine; Neostriatum; Nucleus Accumbens; Oxidopamine; Rats; Rats, Sprague-Dawley; Receptors, Dopamine D1; Receptors, Dopamine D2; Salicylamides; Sympathectomy, Chemical; Synaptosomes | 2009 |
Molecular hydrogen is protective against 6-hydroxydopamine-induced nigrostriatal degeneration in a rat model of Parkinson's disease.
Topics: Administration, Oral; Adrenergic Agents; Animals; Corpus Striatum; Disease Models, Animal; Dopamine; Hydrogen; Immunohistochemistry; Injections, Intraperitoneal; Male; Methamphetamine; Microinjections; Nerve Degeneration; Neurons; Oxidopamine; Parkinson Disease; Rats; Rats, Sprague-Dawley; Substantia Nigra; Tyrosine 3-Monooxygenase | 2009 |
Intranigral transplantation of epigenetically induced BDNF-secreting human mesenchymal stem cells: implications for cell-based therapies in Parkinson's disease.
Topics: Actins; Animals; Brain Injuries; Brain-Derived Neurotrophic Factor; Cell Differentiation; Cell Proliferation; Cell Survival; Culture Media; Culture Media, Serum-Free; Epidermal Growth Factor; Epigenesis, Genetic; Fibroblast Growth Factor 2; Gene Expression; Humans; Intermediate Filament Proteins; Locomotion; Male; Mesenchymal Stem Cell Transplantation; Mesenchymal Stem Cells; Methamphetamine; Nerve Tissue Proteins; Nestin; Neurons; Oxidopamine; Parkinson Disease; Rats; Rats, Sprague-Dawley; Receptor, trkB; Rotation; Substantia Nigra; Tyrosine 3-Monooxygenase | 2010 |
The different performance among motor tasks during the increasing current intensity of deep brain stimulation of the subthalamic nucleus in rats with different degrees of the unilateral striatal lesion.
Topics: Animals; Central Nervous System Stimulants; Corpus Striatum; Deep Brain Stimulation; Disease Models, Animal; Male; Methamphetamine; Microinjections; Motor Skills; Oxidopamine; Parkinson Disease; Rats; Rats, Sprague-Dawley; Subthalamic Nucleus | 2010 |
Methamphetamine-induced dopamine-independent alterations in striatal gene expression in the 6-hydroxydopamine hemiparkinsonian rats.
Topics: Animals; Chromatography, High Pressure Liquid; Corpus Striatum; DNA-Binding Proteins; Dopamine; Dopamine Uptake Inhibitors; Early Growth Response Protein 1; Gene Expression Regulation; Male; Methamphetamine; Nerve Tissue Proteins; Oligonucleotide Array Sequence Analysis; Oxidopamine; Parkinson Disease; Proto-Oncogene Proteins c-fos; Rats; Rats, Sprague-Dawley | 2010 |
Methamphetamine neurotoxicity decreases phasic, but not tonic, dopaminergic signaling in the rat striatum.
Topics: Algorithms; Animals; Central Nervous System Stimulants; Corpus Striatum; Dopamine; Electric Stimulation; Electrophysiological Phenomena; Extracellular Space; Kinetics; Male; Methamphetamine; Microelectrodes; Neurons; Neurotoxicity Syndromes; Oxidopamine; Parkinson Disease, Secondary; Rats; Rats, Sprague-Dawley; Signal Transduction; Sympathectomy, Chemical; Sympatholytics | 2011 |
Low concentrations of methamphetamine can protect dopaminergic cells against a larger oxidative stress injury: mechanistic study.
Topics: Animals; Cell Death; Cell Line; Cytoprotection; Dopamine; Dopamine Plasma Membrane Transport Proteins; Dopaminergic Neurons; Dose-Response Relationship, Drug; Enzyme Activation; Extracellular Signal-Regulated MAP Kinases; JNK Mitogen-Activated Protein Kinases; Methamphetamine; Mice; Mice, Inbred C57BL; Neuroprotective Agents; Oxidative Stress; Oxidopamine; Phosphorylation; Protein Phosphatase 2; Proto-Oncogene Proteins c-akt; Proto-Oncogene Proteins c-bcl-2; Protons; Superoxide Dismutase | 2011 |
ADHD animal model characterization: transcriptomics and proteomics analyses.
Topics: Animals; Animals, Newborn; Attention Deficit Disorder with Hyperactivity; Behavior, Animal; Brain; Disease Models, Animal; Electrophoresis, Gel, Two-Dimensional; Female; Hyperkinesis; Methamphetamine; Oligonucleotide Array Sequence Analysis; Oxidopamine; Pregnancy; Proteomics; Rats; Rats, Wistar; Transcriptome | 2012 |
Pramipexole- and methamphetamine-induced reward-mediated behavior in a rodent model of Parkinson's disease and controls.
Topics: Adrenergic Agents; Analysis of Variance; Animals; Association Learning; Benzothiazoles; Conditioning, Operant; Disease Models, Animal; Dopamine Agents; Dose-Response Relationship, Drug; Forelimb; Male; Methamphetamine; Motor Activity; Nucleus Accumbens; Oxidopamine; Parkinson Disease; Pramipexole; Psychomotor Performance; Rats; Rats, Sprague-Dawley; Reward; Tyrosine 3-Monooxygenase | 2012 |
Golgi fragmentation is Rab and SNARE dependent in cellular models of Parkinson's disease.
Topics: Animals; Golgi Apparatus; Homeostasis; Methamphetamine; Models, Biological; Oxidopamine; Parkinson Disease; PC12 Cells; rab GTP-Binding Proteins; Rats; SNARE Proteins; Structure-Activity Relationship; Tumor Cells, Cultured | 2013 |
Behavioral performance at early (4 weeks) and later (6 months) stages in rats with unilateral medial forebrain bundle and striatal 6-hydroxydopamine lesions.
Topics: Adrenergic Agents; Animals; Behavior, Animal; Bromocriptine; Corpus Striatum; Injections; Male; Medial Forebrain Bundle; Methamphetamine; Motor Skills; Oxidopamine; Parkinsonian Disorders; Rats; Rats, Sprague-Dawley; Receptors, Dopamine D2; Stereotyped Behavior | 2013 |
Effects of the adenosine A2A antagonist istradefylline on cognitive performance in rats with a 6-OHDA lesion in prefrontal cortex.
Topics: Adenosine A2 Receptor Antagonists; Animals; Cognition; Cognition Disorders; Disease Models, Animal; Donepezil; Dopamine; Indans; Male; Memory Disorders; Memory, Short-Term; Methamphetamine; Oxidopamine; Piperidines; Prefrontal Cortex; Purines; Rats; Rats, Sprague-Dawley | 2013 |
Intravenous mesenchymal stem cell administration exhibits therapeutic effects against 6-hydroxydopamine-induced dopaminergic neurodegeneration and glial activation in rats.
Topics: Animals; Dopaminergic Neurons; Female; Humans; Mesenchymal Stem Cell Transplantation; Methamphetamine; Nerve Degeneration; Neuroglia; Oxidopamine; Parkinsonian Disorders; Rats, Sprague-Dawley; Stereotyped Behavior; Substantia Nigra; Tyrosine 3-Monooxygenase | 2015 |
Cannabinoid CB1 receptors activation and coactivation with D2 receptors modulate GABAergic neurotransmission in the globus pallidus and increase motor asymmetry.
Topics: Animals; Arachidonic Acids; GABAergic Neurons; gamma-Aminobutyric Acid; Globus Pallidus; Male; Methamphetamine; Movement; Oxidopamine; Quinpirole; Rats; Rats, Wistar; Receptor, Cannabinoid, CB1; Receptors, Dopamine D2; Synaptic Transmission | 2015 |
Characterization of nociceptive response to chemical, mechanical, and thermal stimuli in adolescent rats with neonatal dopamine depletion.
Topics: Animals; Animals, Newborn; Brain Stem; Dopamine; Dopamine Agents; Formaldehyde; Hot Temperature; Hyperalgesia; Male; Methamphetamine; Motor Activity; Neurons; Oxidopamine; Pain Threshold; Proto-Oncogene Proteins c-fos; Rats, Wistar; Spinal Cord; Touch; Tyrosine 3-Monooxygenase | 2015 |
Failure to suppress low-frequency neuronal oscillatory activity underlies the reduced effectiveness of random patterns of deep brain stimulation.
Topics: Action Potentials; Animals; Central Nervous System Stimulants; Deep Brain Stimulation; Dopamine D2 Receptor Antagonists; Dyskinesia, Drug-Induced; Female; Globus Pallidus; Haloperidol; Implantable Neurostimulators; Methamphetamine; Microelectrodes; Neural Inhibition; Neurons; Oxidopamine; Parkinsonian Disorders; Pars Reticulata; Rats, Long-Evans; Subthalamic Nucleus | 2016 |
Estradiol Facilitates Functional Integration of iPSC-Derived Dopaminergic Neurons into Striatal Neuronal Circuits via Activation of Integrin α5β1.
Topics: Aged; Animals; Cell Differentiation; Cells, Cultured; Corpus Striatum; Dopaminergic Neurons; Estradiol; Female; Gene Expression Profiling; HEK293 Cells; Humans; Induced Pluripotent Stem Cells; Integrin alpha5beta1; Male; Methamphetamine; Mice, Inbred C57BL; Microscopy, Confocal; Nerve Net; Neural Stem Cells; Oxidopamine; Parkinson Disease, Secondary; Rats, Inbred F344; Reverse Transcriptase Polymerase Chain Reaction; Stem Cell Transplantation; Transplantation, Heterologous | 2016 |
Step Sequence Is a Critical Gait Parameter of Unilateral 6-OHDA Parkinson's Rat Models.
Topics: Animals; Disease Models, Animal; Gait; Locomotion; Male; Mesencephalon; Methamphetamine; Neurons; Oxidopamine; Parkinson Disease; Rats, Long-Evans; Rotation; Tyrosine 3-Monooxygenase | 2017 |
Role of Prefrontal Serotonergic and Dopaminergic Systems in Encounter-Induced Hyperactivity in Methamphetamine-Sensitized Mice.
Topics: 5,7-Dihydroxytryptamine; Animals; Central Nervous System Stimulants; Desipramine; Dopamine; Dopamine Agents; Enzyme Inhibitors; Hyperkinesis; Locomotion; Male; Methamphetamine; Mice; Microdialysis; Oxidopamine; Prefrontal Cortex; Proto-Oncogene Proteins c-fos; Serotonin; Serotonin Agents; Social Behavior; Time Factors | 2017 |
A novel biosensor with high signal-to-noise ratio for real-time measurement of dopamine levels in vivo.
Topics: Animals; Biosensing Techniques; Carbon Fiber; Corpus Striatum; Dopamine; Electric Stimulation; Electrochemical Techniques; Electrodes; Flow Injection Analysis; Male; Methamphetamine; Monoamine Oxidase; Norepinephrine; Oxidopamine; Rats; Rats, Wistar; Serotonin; Signal-To-Noise Ratio | 2018 |
Differential effects of dopaminergic drugs on spontaneous motor activity in the common marmoset following pretreatment with a bilateral brain infusion of 6-hydroxydopamine.
Topics: Animals; Apomorphine; Area Under Curve; Callithrix; Corpus Striatum; Disease Models, Animal; Dopamine Agents; Dopaminergic Neurons; Dose-Response Relationship, Drug; Immunohistochemistry; Levodopa; Male; Methamphetamine; Motor Activity; Oxidopamine; Parkinsonian Disorders; Substantia Nigra; Tyrosine 3-Monooxygenase | 2017 |
Behavioral responses to anxiogenic tasks in young adult rats with neonatal dopamine depletion.
Topics: Adrenergic Uptake Inhibitors; Animals; Animals, Newborn; Anxiety; Atomoxetine Hydrochloride; Behavior, Animal; Dopamine; Dopamine Uptake Inhibitors; Exploratory Behavior; Female; Lighting; Maze Learning; Methamphetamine; Motor Activity; Nerve Net; Oxidopamine; Pregnancy; Rats; Rats, Wistar | 2019 |